CFO sold ~$59K of Hims & Hers Health
Scheduled in advanceLoading…
HIMS · NYSE · Health Care Services
Health Care Services company based in San Francisco, California.
In the last 90 days, no insider of Hims & Hers Health reported an open-market purchase and 14 open-market sales worth about $6.03M. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$29.67
Last 12 months
Not enough history
Market value
Not available
Revenue
$753M
+38.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$61.5M
This quarter −$68.2M, a year earlier −$69.5M
Net debt
—
Debt —, cash $610M, at Jun 30, 2026
Net income, last 12 months
−$142M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 10, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
14 sales
$6.03M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$2.35B
+59.0% vs the year before
Net income, fiscal 2025
$128M
As reported in the annual filing
Shares outstanding
Not available
Reported per share class only, with no single total
In fiscal 2025 the company spent $90M buying back its own shares. Cash actually paid, from its cash-flow statement.
CFO sold ~$59K of Hims & Hers Health
Scheduled in advanceOfficer sold ~$101K of Hims & Hers Health
Scheduled in advanceCFO sold ~$877K of Hims & Hers Health
Scheduled in advanceOfficer sold ~$398K of Hims & Hers Health
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $54.76 on Oct 6, 2025 to $29.67 on Oct 5, 2026 (-45.8%). Disclosed activity in the last 12 months: 1 insider purchase, 57 insider sales (56 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Top officer leaving
“(the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.”
5 insiders sold ~$5.6M in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.